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Kinetic constants of glycogen synthase (MO 5 for glucose-6-P and So.5 for UDP-glucose) were determined 
after hepatocytes i olated from starved rats were incubated with either glucagon or epinephrine. Incubation 
with these hormones resulted in an increase in both SO 5 and A4 0.5. However, the action of glucagon resulted 
in great modifications on So.5 whereas epinephrine affected mainly A40.5. Therefore, glucagon and 
epinephrine alter the kinetic properties of glycogen synthase provoke the phosphorylation of glycogen 
synthase at different site(s) acting through different mechanisms. 
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1. INTRODUCTION 
Glycogen synthase has been recognized as an 
enzyme regulated by covalent phosphorylation and 
dephosphorylation [l]. It is now accepted that it 
contains several phosphorylation sites per subunit 
which can be phosphorylated by several protein 
kinases, each kinase acting on specific site(s) [2,3]. 
Cyclic AMP-dependent protein kinases and cyclic 
AMP-independent protein kinases have been re- 
cently described to be present in rat liver [4-81. 
Phosporylation results in the increase in So.5 for 
the substrate (UDP-glucose) and Mo.5 for the acti- 
vator (glucose-6-P) which lead to the inactivation 
of the enzyme [9,10]. 
Glucagon and epinephrine trigger the inactiva- 
tion of the liver enzyme [ 11,121. However, although 
the action of glucagon can be reasonably explained 
by the activation of the cyclic AMP-dependent 
protein kinase, no evidence on the mechanism of 
action of epinephrine is available. Therefore, it is 
not known whether or not the action of epine- 
phrine results in the phosphorylation of the same 
sites of the enzyme as those phosphorylated by the 
action of glucagon. 
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Here, we present data on the changes in the 
kinetic constants provoked by glucagon and epine- 
phrine on glycogen synthase from rat hepatocytes. 
These data show that glucagon and epinephrine 
alter the kinetic properties of liver glycogen syn- 
thase in a different manner. It is then concluded 
that these two hormones provoke the phosphoryla- 
tion of glycogen synthase at a different site(s). 
2. MATERIALS AND METHODS 
Suspensions of isolated parenchymal iver cells 
were prepared from starved (24 h) male Wistar rats 
(200-250 g) as in [ 131. Cells were finally resus- 
pended in Krebs bicarbonate buffer (pH 7.4) free 
from glucose or any other substrate, and pre-gassed 
with 02/CO2 (19: 1). Aliquots (5 ml, 8-9 x lo6 
cells/ml) were poured into stoppered vials, incu- 
bated at 37°C and shaken (100 strokes/min). At 
the end of the incubations the content of each vial 
was centrifuged (3000 x g, 20 s) and the cell pellet 
was immediately homogenized with 150 ,J ice-cold 
medium containing 300 mM KF and 30 mM EDTA 
(pH 7.0). 
The cell homogenates were centrifuged at 
10000 x g for 15 min, and the supernatants were fil- 
tered through Ultrogel AcA 202 columns (1 cm x 15 
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cm) and equilibrated with 150 mM KF and 15 mM 
EDTA (pH 7.0), all at 4°C. The protein eluate was 
divided into two (500 ~1 + 300 ~1) aliquots. The 
first was directly assayed for glycogen synthase 
activity using the -G6P/+G6P standard assay 
[14]. Similarly, in this aliquot, MO.S was estimated 
from Hill plots of log(J’Jl/a,max - V,) vs log[glu- 
case-6-P] as in [lo]. The second 300~~1 aliquot was 
incubated for 30 min at 4”C, with 2 units glu- 
cose-6-P dehydrogenase and 0.13 ,umol NADP to 
eliminate any trace of glucose-6-P remaining after 
column process. So.5 was then estimated from Hill 
plots of log(V/& - V) vs log[UDP-glucose] as in 
POI. 
Protein was determined by the biuret method 
[15] as in [16]. All the chemical reagents used were 
Analytical Grade and obtained from Sigma or 
Merck. Collagenase came from Worthington, and 
bovine serum albumin (fraction V), glucagon and 
epinephrine from Sigma. 
3. RESULTS 
When hepatocytes isolated from 24-h starved 
rats were incubated for 10 min with increasing con- 
centrations of glucagon or epinephrine, dose- 
dependent increases in So.5 for UDP-glucose and 
M0.5 for glucose-6-P were observed (fig.1). How- 
ever, the observed increases in So.5 after incubation 
with glucagon were much greater than those pro- 
Fig.1. Dose-dependence of the effects of glucagon and 
epinephrine on So.5 for UDP-glucose and Mo.5 for 
glucose-6-P. Cells were incubated for 10 min with the 
indicated concentrations of the hormones. Results are 
mean f SE of at least 5 expt. 
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Fig. 2. Results in fig. 1 were replotted as So.5 vs Mo.5. 
duced after incubation with epinephrine. On the 
other hand, epinephrine provoked greater increases 
in Mo.5 than did glucagon. 
After replotting So.5 vs Mo.s-values for glycogen 
synthase of cells incubated with increasing concen- 
trations of glucagon or epinephrine, the resulting 
curves were at variance (fig.2). 
4. DISCUSSION 
Glycogen synthase undergoes multiple phos- 
phorylation. Phosphorylation results in an increase 
in the values of So.5 for UDP-glucose and Mo.5 for 
glucose-6-P [9,10]. Therefore, the more phos- 
phorylated forms are less active than the de- 
phosphorylated forms. 
It seems logical to accept that UDP-glucose and 
glucose-6-P bind the enzyme at different sites. 
UDP-glucose binds at the active site, while glu- 
cose-6-P binds at an allosteric one. Therefore, the 
quantitative changes that the phosphorylation of a 
particular site exerts on So.5 and MO.S should be 
interpreted as the result of the modifications that 
the introduction of a phosphate in that phosphory- 
lation site may exert on the configuration of both 
the active and the allosteric sites. 
Although the phosphorylation of most sites 
seems to be able to exert effects on both the active 
and allosteric sites, it appears rather unlikely that 
the modifications produced by the phosphoryla- 
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tion of two different phosphorylation sites exert 
identical effects on the active and allosteric sites; 
i.e., it seems logical to assume that the phosphory- 
lation of a site would produce deeper modifica- 
tions on the active site than on the allosteric one, 
while the phosphorylation of other sites would 
have the opposite effect. 
The plotting of So.5 vs MO.S for samples of glyco- 
gen synthase increasingly phosphorylated by a 
certain protein kinase expresses how the phos- 
phorylation of the centers available to that kinase 
relatively alter the active and the allosteric sites. 
Therefore, it is likely that if two kinases follow dif- 
ferent patterns of phosphorylation, the two plots 
of So.5 vs MO.S for the resulting species of glycogen 
synthase will be at variance. 
Both So.5 and MO.S are affected by the incubation 
of rat hepatocytes either with glucagon or epine- 
phrine. The action of glucagon results in great 
modifications on SO.S whereas epinephrine affects 
mainly Mo.5. Therefore, the plotting of So.5 vs M0.5 
for glycogen synthase from cells treated with in- 
creasing concentrations of glucagon differs from 
that obtained from cells treated with epinephrine. 
These results suggest hat the species of glycogen 
synthase resulting from the incubation of the cells 
with glucagon and epinephrine, are different as 
indicated by their different kinetic characteristics. 
This different behaviour can logically be attributed 
to the phosphorylation of different sites in response 
to glucagon or epinephrine. 
Although it is widely accepted that the actions of 
glucagon and epinephrine on liver glycogen syn- 
thase metabolism have to be exerted through dif- 
ferent mechanisms, this is the first time evidence 
has been obtained showing that the two hormones 
affect glycogen synthase in a different manner 
leaving their distinct imprints in the enzyme. There- 
fore, although both hormones inactivate glycogen 
synthase, the resulting inactive enzyme is not exact- 
ly the same in both cases. 
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